|
Volumn 28, Issue 1-2, 2001, Pages 74-78
|
A predicted cortical serotonergic/cholinergic/gabaergic interface as a site of pathology in schizophrenia
|
Author keywords
5 hydroxytryptamine; Acetylcholine; Frontal cortex; GABA; Post mortem; Schizophrenia; Serotonin
|
Indexed keywords
4 AMINOBUTYRIC ACID A RECEPTOR;
ACETYLCHOLINE;
DOPAMINE;
KETANSERIN;
LYSERGIC ACID;
MUSCARINIC M1 RECEPTOR;
PIRENZEPINE;
SEROTONIN;
SEROTONIN 2A RECEPTOR;
SEROTONIN AGONIST;
ANIMAL CELL;
ANIMAL TISSUE;
BINDING SITE;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
CYTOARCHITECTURE;
FRONTAL CORTEX;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
NEUROPATHOLOGY;
NONHUMAN;
PATHOPHYSIOLOGY;
PROTEIN INTERACTION;
RECEPTOR BINDING;
RECEPTOR DENSITY;
SCHIZOPHRENIA;
SEROTONIN RELEASE;
FRONTAL LOBE;
HUMANS;
KETANSERIN;
MODELS, NEUROLOGICAL;
PIRENZEPINE;
RECEPTOR, MUSCARINIC M1;
RECEPTORS, GABA-A;
RECEPTORS, MUSCARINIC;
RECEPTORS, SEROTONIN;
RECEPTORS, SEROTONIN, 5-HT1;
SCHIZOPHRENIA;
SEROTONIN ANTAGONISTS;
|
EID: 0035170838
PISSN: 03051870
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1440-1681.2001.03401.x Document Type: Conference Paper |
Times cited : (26)
|
References (38)
|